411 research outputs found
Recommended from our members
Direct methanol fuel cells: Developments for portable power and for potential transportation applications
The authors describe here results of recent efforts at Los Alamos National Laboratory (LANL), devoted to potential application of Direct Methanol Fuel Cells (DMFCs) as (1) portable power sources at the 50 W level, and (2) primary power sources for electric vehicles. In general, DMFC R and D efforts focus on further improvements in anode catalytic activity, fuel utilization (as related to methanol crossover) and air cathode performance in the presence of the presence of the significant flux of aqueous methanol from anode to cathode. There are significant differences between technical parameters and targets for the two different DMFC applications, which the authors have addressed. They include the lower cell temperature (about 60 C) preferred in portable power vs. operation around 100 C as target temperature for transportation applications, and the much stronger concern for cost of catalyst and any other stack materials in DMFCs developed for potential transportation applications. Most, if not all, recent DMFC work for either portable power or potential transportation applications has strongly focused on cells with polymeric (primarily PFSA) membrane electrolytes. In work at LANL, thin film catalysts bonded to the membrane, e.g., by the decal method, provided best results in terms of catalyst utilization and overall cell performance. In most tests, the single DMFC hardware consisted of uncatalyzed carbon-cloth gas-diffusion backings and graphite blocks with machined serpentine flow channels--quite similar to hardware employed in work with hydrogen/air PEFCs. However, the machined graphite hardware has recently been replaced by alternative, non-machined flow-field/bipolar plates, which enables effective air and aqueous methanol solution distribution along an active area of 50 cm{sup 2}, at a pitch per cell of 2 mm
Gitksan medicinal plants-cultural choice and efficacy
BACKGROUND: The use of plants for healing by any cultural group is integrally related to local concepts of the nature of disease, the nature of plants, and the world view of the culture. The physical and chemical properties of the plants themselves also bear on their selection by people for medicines, as does the array of plants available for people to choose from. I examine use of medicinal plants from a "biobehavioral" perspective to illuminate cultural selection of plants used for medicine by the Gitksan of northwestern British Columbia, Canada. METHODS: Consultant consensus, "intercultural consensus", independent use of the same plants by other cultural groups, and phytochemistry and bioassay results from the literature, were employed in analysis of probable empirical efficacy of plant uses. RESULTS: 70% of 37 Gitksan medicinal plants were used similarly by other cultures where direct diffusion is not known to have occurred; eleven plants, including the eight most frequently mentioned medicinal plants, also show active phytochemicals or bioassays indicating probable physiologically based therapeutic effects. CONCLUSION: Analysis of intercultural consensus revealed that the majority of cultures in the British Columbia region within the plant ranges use the same plants, or closely related species, in similar ways. The rigor of this analysis is effected by the lack of consistent data on all taxa of interest for all cultures within the region
Genome-Wide Identification of Bcl11b Gene Targets Reveals Role in Brain-Derived Neurotrophic Factor Signaling
B-cell leukemia/lymphoma 11B (Bcl11b) is a transcription factor showing predominant expression in the striatum. To date, there are no known gene targets of Bcl11b in the nervous system. Here, we define targets for Bcl11b in striatal cells by performing chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) in combination with genome-wide expression profiling. Transcriptome-wide analysis revealed that 694 genes were significantly altered in striatal cells over-expressing Bcl11b, including genes showing striatal-enriched expression similar to Bcl11b. ChIP-seq analysis demonstrated that Bcl11b bound a mixture of coding and non-coding sequences that were within 10 kb of the transcription start site of an annotated gene. Integrating all ChIP-seq hits with the microarray expression data, 248 direct targets of Bcl11b were identified. Functional analysis on the integrated gene target list identified several zinc-finger encoding genes as Bcl11b targets, and further revealed a significant association of Bcl11b to brain-derived neurotrophic factor/neurotrophin signaling. Analysis of ChIP-seq binding regions revealed significant consensus DNA binding motifs for Bcl11b. These data implicate Bcl11b as a novel regulator of the BDNF signaling pathway, which is disrupted in many neurological disorders. Specific targeting of the Bcl11b-DNA interaction could represent a novel therapeutic approach to lowering BDNF signaling specifically in striatal cells
Analysis of 17,576 Potentially Functional SNPs in Three Case–Control Studies of Myocardial Infarction
Myocardial infarction (MI) is a common complex disease with a genetic component. While several single nucleotide polymorphisms (SNPs) have been reported to be associated with risk of MI, they do not fully explain the observed genetic component of MI. We have been investigating the association between MI and SNPs that are located in genes and have the potential to affect gene function or expression. We have previously published studies that tested about 12,000 SNPs for association with risk of MI, early-onset MI, or coronary stenosis. In the current study we tested 17,576 SNPs that could affect gene function or expression. In order to use genotyping resources efficiently, we staged the testing of these SNPs in three case–control studies of MI. In the first study (762 cases, 857 controls) we tested 17,576 SNPs and found 1,949 SNPs that were associated with MI (P<0.05). We tested these 1,949 SNPs in a second study (579 cases and 1159 controls) and found that 24 SNPs were associated with MI (1-sided P<0.05) and had the same risk alleles in the first and second study. Finally, we tested these 24 SNPs in a third study (475 cases and 619 controls) and found that 5 SNPs in 4 genes (ENO1, FXN (2 SNPs), HLA-DPB2, and LPA) were associated with MI in the third study (1-sided P<0.05), and had the same risk alleles in all three studies. The false discovery rate for this group of 5 SNPs was 0.23. Thus, we have identified 5 SNPs that merit further examination for their potential association with MI. One of these SNPs (in LPA), has been previously shown to be associated with risk of cardiovascular disease in other studies
3D Volume Reconstruction by Serially Acquired 2D Slices Using a Distance Transform-Based Global Cost Function
Abstract. An accurate, computationally eÆcient and fully-automated algorithm for the alignment of 2D serially acquired sections forming a 3D volume is presented. The method accounts for the main shortcomings of 3D image alignment: corrupted data (cuts and tears), dissimilarities or discontinuities between slices, missing slices. The approach relies on the optimization of a global energy function, based on the object shape, measuring the similarity between a slice and its neighborhood in the 3D volume. Slice similarity is computed using the distance transform measure in both directions. No particular direction is privileged in the method avoiding global osets, biases in the estimation and error prop-agation. The method was evaluated on real images (medical, biological and other CT scanned 3D data) and the experimental results demon-strated the method's accuracy as reconstuction errors are less than 1 degree in rotation and less than 1 pixel in translation.
Health hazards of China’s lead-acid battery industry: a review of its market drivers, production processes, and health impacts
Structural Basis for Cyclic Py-Im Polyamide Allosteric Inhibition of Nuclear Receptor Binding
Pyrrole-imidazole polyamides are a class of small molecules that can be programmed to bind a broad repertoire of DNA sequences, disrupt transcription factor−DNA interfaces, and modulate gene expression pathways in cell culture experiments. In this paper we describe a high-resolution X-ray crystal structure of a β-amino turn-linked eight-ring cyclic Py-Im polyamide bound to the central six base pairs of the sequence d(5′-CCAGTACTGG-3′)_2, revealing significant modulation of DNA shape. We compare the DNA structural perturbations induced by DNA-binding transcripton factors, androgen receptor and glucocorticoid receptor, in the major groove to those induced by cyclic polyamide binding in the minor groove. The cyclic polyamide is an allosteric modulator that perturbs the DNA structure in such a way that nuclear receptor protein binding is no longer compatible. This allosteric perturbation of the DNA helix provides a molecular basis for disruption of transcription factor−DNA interfaces by small molecules, a minimum step in chemical control of gene networks
- …